Advertisement

Journal of Radioanalytical and Nuclear Chemistry

, Volume 283, Issue 2, pp 273–278 | Cite as

Radiolabeling of thioguanine with 125I for diagnosis and therapy: in vitro and in vivo evaluation

  • A. M. Amin
  • S. E. Soliman
  • H. M. Killa
  • H. A. El-Aziz
Article

Abstract

Labeling was carried out by direct iodination of thioguanine (100 μg) with radioiodine in a fast single step at 60 °C, to produce iodo-6-thioguanine (125I-S6G). Chloramine-T (200 μg) was used as oxidizing agent to oxidize the iodide ion to the iodonium ion, at pH 7 and the reaction time was 30 min. A high radiochemical yield of 96.4% was obtained. The labeled compound was quantitatively separated and purified by means of high pressure liquid chromatography (HPLC) with a radiochemical purity greater than 98%, which facilitates its clinical use for human application. The biodistribution of 125I-6-thioguanine was studied by injection of the tracer in both normal and tumor bearing mice. The uptake in ascetic fluid was 35.4 and 23.9% at 1 and 24 h post intravenous injection (h.p.i.), respectively, indicating the suitability of this labeled compound for use as a radiopharmaceutical agent.

Keywords

125Thioguanine Radioiodination Biodistribution 

Notes

Acknowledgements

The authors wish to thank the editor and the referees of the JRNC for their cooperation and valuable comments and also Prof. Dr. K. Farah for her efforts in reviewing the manuscript.

References

  1. 1.
    Elion GB (1989) Science 244:41CrossRefGoogle Scholar
  2. 2.
    Bohon J, de los Santos CR (2005) Nucleic Acids Res 33(9):2880CrossRefGoogle Scholar
  3. 3.
    Krynetskaia NF, Cai X, Nitiss JL, Krynetski EY, Relling MV (2000) FASEB J 14:2339CrossRefGoogle Scholar
  4. 4.
    Bignami M, O’Driscoll M, Aquilinia G, Karran P (2000) Mutat Res 462:71CrossRefGoogle Scholar
  5. 5.
    de las Alas MM, Los G, Lin X, Kurdi-Haidar B, Manorek G, Howell S (2002) Mol Pharmacol 62:1198CrossRefGoogle Scholar
  6. 6.
    Yan T, Berry SE, Desai AB, Kinsella T (2003) J Clin Cancer Res 9:2327Google Scholar
  7. 7.
    Krynetskaia NF, Feng JY, Krynetski EY, Garcia JV, Panetta JC, Anderson KS, Evans WE (2001) FASEB J 15:1902CrossRefGoogle Scholar
  8. 8.
    Maybaum J, Mandel HG (1983) Cancer Res 43:3852Google Scholar
  9. 9.
    Bugg CE, Thewalt U (1970) J Am Chem Soc 92:7441CrossRefGoogle Scholar
  10. 10.
    Marathias VM, Sawicki MJ, Bolton PH (1999) Nucleic Acids Res 27:2860CrossRefGoogle Scholar
  11. 11.
    Singh K, Groth-Vasselli B, Farnsworth P, Rai D (1996) Res Commun Mol Pathol Pharmacol 94:129Google Scholar
  12. 12.
    Sponer J, Leszczynski J, Hobza P (1997) J Phys Chem 101:9489Google Scholar
  13. 13.
    Bohon J, de los Santos C (2003) Nucleic Acids Res 31:1331CrossRefGoogle Scholar
  14. 14.
    Sommervile L, Krynetski EY, Krynetskaia NF, Beger RD, Zhang W, Marhefka CA, Evans WE, Kriwacki RW (2003) J Biol Chem 278:1005CrossRefGoogle Scholar
  15. 15.
    EL-Ghany EA, Mahdy MA, Attallah K, Ghazy FS (2002) J Radioanal Nucl Chem 252(1):165CrossRefGoogle Scholar
  16. 16.
    Asikoglu M, Yurt F, Cagliyan O, Unak P, Ozkilic H (2000) Appl Radiat Isot 53:411CrossRefGoogle Scholar
  17. 17.
    K. Attallah (2002) M.Sc. Pharmaceutics, EAEA, p 91Google Scholar
  18. 18.
    Rhodes BA (1974) Semin Nucl Med 4:281CrossRefGoogle Scholar
  19. 19.
    Knust EJ, Dutschka K, Machulla HJ (1990) J Radioanal Nucl Chem Lett 144:107CrossRefGoogle Scholar
  20. 20.
    Cynthia BF, Roger KD, Kaumann AJ, Theodore LS, Lutz B (1979) J Mol Pharmacol 12:328Google Scholar
  21. 21.
    Rayudu GVS (1983) Radiotracers for medical application, CRS series in Radiotracers in Biology and Medicine vol 11Google Scholar
  22. 22.
    Saccavini JC, Bruneau C (1984) IAEA CN 4519:153Google Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2009

Authors and Affiliations

  • A. M. Amin
    • 1
  • S. E. Soliman
    • 2
  • H. M. Killa
    • 3
  • H. A. El-Aziz
    • 4
  1. 1.Labeled Compounds Department, Hot Laboratories CenterAtomic Energy AuthorityCairoEgypt
  2. 2.Hot Laboratories CenterAtomic Energy AuthorityCairoEgypt
  3. 3.Faculty of ScienceZagazig UniversityZagazigEgypt
  4. 4.Radioisotope Production ProjectAtomic Energy AuthorityCairoEgypt

Personalised recommendations